Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

NCT02908217 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: Tocilizumab
DRUG: Placebo

Sponsor

University Hospital, Brest

Collaborators

[object Object]